H-ASSIST: Ultra Hypo-fractionated WBI with SIB for Early-Stage Breast Cancer

UNC Lineberger Comprehensive Cancer Center is evaluating a 5-fraction whole breast irradiation regimen with a simultaneous integrated tumor bed boost in early-stage breast cancer and ductal carcinoma in situ to assess radiation-specific toxicity, quality of life, and oncologic outcomes. The study builds on the FAST-Forward trial findings by minimizing treatment visits while aiming to lower recurrence risks.